Sort
78,016 grants matching “breast cancer”
Non-Invasive MRI-Guided HIFU for Breast Cancer Therapy
$559,888Dennis L Parker · University Of Utah · R01 · FY2016 · CA
P63 IN EPITHELIAL CELL PROLIFERATION AND DIFFERENTIATION
$559,874Harvard University (Medical School) · R01 · FY2002 · CA
Mechanisms of paclitaxel sensitivity and resistance
$559,860Beth A Weaver · University Of Wisconsin-Madison · R01 · FY2025 · CA
Identification of Citrullinated Biomarkers of Inflammatory Disease and Cancer
$559,848Paul R Thompson · Univ Of Massachusetts Med Sch Worcester · R01 · FY2014 · GM
BRMS1-mediated suppression of metastases in p53 mutant lung adenocarcinoma
$559,847David R Jones · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
BRMS1-mediated suppression of metastases in p53 mutant lung adenocarcinoma
$559,847David R Jones · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Mechanisms of BET bromodomain metabolic reprogramming in triple negative breast cancer
$559,846Gerald V Denis · Boston University Medical Campus · R01 · FY2018 · CA
The Tumor Microenvironment and Lymphatic Remodeling in Postpartum Breast Cancer
$559,840Jasmine Alise McDonald · Columbia University Health Sciences · R01 · FY2023 · CA
Chemotherapy & Cognition in Older breast Cancer Patients
$559,792James P Grigsby · University Of Colorado Denver · R01 · FY2006 · AG
Synergistic combinatorial DNA damage response/repair inhibition and Sacituzumab Govitecan in triple-negative breast cancer
$559,783Leif W Ellisen · Massachusetts General Hospital · R01 · FY2025 · CA
Synergistic combinatorial DNA damage response/repair inhibition and Sacituzumab Govitecan in triple-negative breast cancer
$559,783Leif W Ellisen · Massachusetts General Hospital · R01 · FY2022 · CA
(7) Novel imaging devices for measurement and control of tumor microenvironments
$559,773John S Condeelis · Albert Einstein College Of Medicine · R01 · FY2019 · CA
Increasing the diagnostic yield of low-risk bronchial biopsy in the evaluation of
$559,763Melissa J Suter · Massachusetts General Hospital · R01 · FY2013 · CA
Evaluation of Di-indolylmethane supplementation to modulate tamoxifen efficacy in
$559,749Cynthia A Thomson · University Of Arizona · R01 · FY2012 · CA
Role of the p53 C-terminal domain in tissue homeostasis, tumor suppression, and oncogenesis
$559,746James J. Manfredi · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · CA
Aim 2: Network-level modeling of single-agent and combination therapy
$559,714Peter Karl Sorger · Harvard Medical School · P50 · FY2015 · GM
(PQA-5) DNA methylation and cancer prevention: duration and intensity of exercise
$559,672Angela D Bryan · University Of Colorado · R01 · FY2013 · CA
Breast CT: Final Steps to Translation
$559,655John M Boone · University Of California At Davis · R01 · FY2018 · CA
INTERACTIVE DECISION AID FOR BRCA 1/2 MUTATION CARRIERS
$559,604Georgetown University · R01 · FY2002 · CA
Mechanism of Actin mRNA Localization and Localized Translation in Neurons
$559,574Robert H Singer · Albert Einstein College Of Medicine, Inc · R01 · FY2016 · NS
Effect of n-3 fatty acids and sugars on chemotherapy-induced cognitive deficits
$559,544Tonya S Orchard · Ohio State University · R01 · FY2016 · CA
Developing an in vitro to in vivo pipeline of mammary gland exposure-response relationships to per- and poly-fluoroalkyl substances (PFAS)
$559,511Amy L Oldenburg · Univ Of North Carolina Chapel Hill · R01 · FY2020 · ES
Lung cancer molecular markers by sex: intergroup study
$559,505Christine B. Ambrosone · Roswell Park Cancer Institute Corp · R01 · FY2008 · CA
Admixture Mapping for Breast Cancer in Latinas
$559,501Elad Ziv · University Of California, San Francisco · R01 · FY2010 · CA
Imaging and Targeting Metastatic-Prone Breast Cancer
$559,473Ronald G Blasberg · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA